NCT04874064View on ClinicalTrials.gov

TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence

UnknownOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

December 5, 2019

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2023

Conditions
Breast Cancer
Interventions
OTHER

Liquid Biopsy

Blood collection and access to residual tumor.

Trial Locations (4)

N6A 4V2

RECRUITING

St. Joseph's Health Care London, London

K1H 8L6

RECRUITING

The Ottawa Hospital Cancer Center, Ottawa

M4N 3M5

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

H3T 1E1

RECRUITING

Jewish General Hospital, Montreal

Sponsors

Collaborators (1)

Exactis Innovation
All Listed Sponsors
collaborator

Exactis Innovation

OTHER

lead

Jewish General Hospital

OTHER

NCT04874064 - TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence | Biotech Hunter | Biotech Hunter